Hypocalcemia in Pregnancy: A Clinical Review Update

Abstract

Though hypocalcemia in pregnancy is not often reported in the literature, it occurs in cases of hypoparathyroidism and in mothers with severe dietary inadequacy. Hypocalcemia during pregnancy can pose numerous problems to the mother and fetus. It is associated with hypertensive disorders and can increase the risk of numerous problems such as preeclampsia and fetal growth disorders. In this review, we summarize the challenges physicians face diagnosing and managing hypocalcemia during pregnancy. A multidisciplinary team including endocrinologists and obstetricians is warranted to ensure appropriate treatment and optimal outcomes.

Introduction

Calcium levels affect many extracellular and intracellular processes. These include neural transmission, membrane stability, bone structure, blood coagulation, muscle movement, and intracellular signaling. It is also an important cofactor for hormonal secretion in endocrine organs.¹ For optimal and normal functioning of these processes, the total serum calcium concentrations need to be normally maintained within the very narrow range of 8.5 and 10.5 mg/dL (2.12 to 2.62 mmol/L).^2,3 Hypocalcemia, a common metabolic derangement observed in hospitalized patients (both medical and surgical), is caused by loss of calcium from circulation or insufficient entry of calcium into the circulation.

Calcium is the substrate for bone mineralization. Skeletal mass cannot be built or maintained if calcium intake is insufficient or calcium losses are excessive. In humans, more than 99% of calcium is stored as hydroxyapatite in bones and the rest (5–6 g) is in the intracellular and extracellular compartments, with only 1.3 g located extracellularly. Half of plasma calcium is in a free or ionized state, and only this ionized calcium is metabolically active and affects the body’s functions. Of the remaining plasma calcium, 40% is transported partly bound to plasma proteins (90% of this is bound to albumin), and the rest is bound to small anions such as phosphate, carbonate, citrate, lactate, and sulfate.^3,4

Calcium regulation

Around 10–20 mEq/day of calcium is utilized by the body. In operational terms, calcium balance is determined by the relationship between calcium intake, calcium absorption, and excretion. Daily, the calcium removed from bones is replenished by an equal amount (500 mg). The amount of calcium absorbed by the intestines is equated by urinary calcium excretion. Despite calcium fluctuations, in a healthy person, the levels of ionized calcium are tightly regulated by the two main calcium regulating hormones (parathyroid hormone (PTH) and calcitonin) and the prohormone, vitamin D, and three organs (bone, kidney, and small intestine) through complex feedback loops.⁵ Table 1 summarizes the actions of each hormone and the role of the organs in calcium regulation. Insufficient levels of vitamin D or PTH or resistance to these hormones causes chronic hypocalcemia. Serum pH, protein, and anion levels also play a role in serum calcium levels.

Table 1. Actions of hormones regulating calcium.^6,7.

Hormones/prohormone (function)	Organ (action on calcium deprivation)
PTH (PTH’s function is to control calcium concentration in the extracellular fluid using their membrane receptor, which acts as a calcium sensor). The ionized calcium in the extracellular fluid is the principal signal regulating PTH secretion. PTH secretion is stimulated as calcium level decreases. Calcium also regulates PTH gene activity.	Kidney - Rapid effect on kidney causing reabsorption of calcium and excretion of phosphorus to maintain calcium level and prevent adverse effects of elevated phosphate from bone resorption. Calcium loss through urine is reduced. Bones - Increased rate of calcium and phosphate release from the bones by PTH binding to the osteoblasts causing release of cytokines and increased osteoclast activity. There is net loss of bone and rise in blood calcium levels.
1,25-(OH)2 vitamin D (calcitriol) (Vitamin D must be metabolically activated by PTH stimulation before it can regulate calcium levels and influence skeletal remodelling. 1,25-(OH)2 vitamin D decreases PTH gene expression creating a negative feedback loop for the regulation of PTH. Activation through hydroxylation stimulated as calcium levels decrease due to increased PTH secretion). Calcitonin (which is produced by the parafollicular (or C) cells of the thyroid, has the opposite effect on blood calcium levels as PTH. Very low-level secretion when calcium levels are low).	Small intestine - 1,25-(OH)2 vitamin D promotes enhanced absorption of dietary calcium from the small intestine through the intestinal epithelial cell. Bones - 1,25-(OH)2 vitamin D activates osteoblasts/osteoclasts leading to calcium and phosphate release from the bone. Kidney - Renal excretion of calcium is decreased due to enhanced tubular reabsorption stimulated by elevated PTH and vitamin D. Although calcitonin has a pharmacologic role in calcium disorders, its physiologic role in calcium homeostasis is unclear. When serum calcium increases, calcitonin decreases blood calcium levels by inhibiting osteoclasts, stimulating osteoblasts, inhibiting bone resorption, and stimulating calcium excretion by the kidneys. It does not play a major role in humans at least in adults.

PTH: parathyroid hormone; 1,25-(OH)2 vitamin D: 1,25-dihydroxy vitamin D.

According to the National Institute of Health, the recommended daily calcium dietary allowance in normal females aged 19–50 years during pregnancy and lactation is 1000 mg, and 1300 mg in normal females aged 14–18 years old.

Calcium deficiency in women

Calcium deficiency has numerous implications in women from the fetal phase to the elderly post-menopausal age since the body has increased calcium needs during growth spurts, pregnancy, and lactation. Inadequate calcium intake can, therefore, cause several problems especially in growing children and adolescents; this can lead to stunted growth, and a reduced peak bone density increases the risk of osteoporosis later in life.¹

Calcium deficiency during pregnancy and lactation

Total serum calcium normally falls throughout pregnancy, thus a healthy and balanced maternal diet is crucial since the diet needs to take care of the women’s usual nutritional needs as well as the needs of the growing fetus, enabling the mother to maintain her stores of nutrients and those required for fetal health as well as for the future breastfeeding period.⁸ Many physiologic changes occur during pregnancy resulting in an increase of red blood cells and plasma volume and a reduction of micronutrients and circulating nutrient-binding proteins. In most developing countries, poor nutrition combined with the usual physiologic pregnancy changes can lead to micronutrient deficiency states⁹ like calcium deficiency, which can have detrimental effects on bone health since the bone stores most of the body’s calcium and replaces extracellular fluid losses. Women are at risk when they already have hypocalcemia and have to undergo the strain on their bodies to meet the normal maternal needs with the additional needs of calcium during pregnancy and lactation.

Adaptation by the mother

The mother adapts in various ways to meet the additional calcium needs. Though similar, the increased demands during pregnancy and lactation may involve different alterations in intestinal calcium absorption and excretion, mobilization of calcium from the maternal skeleton, and/or rates of bone calcium turnover^10,11 as shown in Figure 1.

Figure 1.

Contrasting calcium homeostasis in human pregnancy and lactation, as compared to normal. The thickness of arrows indicates a relative increase or decrease with respect to the normal and non-pregnant state. The direct and possible indirect stimulation of plasma prolactin is also shown.

The main adaptation through which women meet the calcium demands of pregnancy is by the doubling of their intestinal calcium absorption driven by calcitriol and other factors as early as 12 weeks gestation.¹⁰ This early increased absorption of calcium may allow the maternal skeleton to store more calcium in advance of the peak fetal demand that occurs in the third trimester. The 24-hour urine calcium also increases by 12 weeks gestation and may exceed the normal range.¹² While in the fasting state, urine calcium can be normal or low; the increase in the 24-hour urine calcium indicates an increase in intestinal calcium absorption. Elevated calcitonin values in pregnancy may also induce renal calcium excretion.

Contrary to notions that the women may suffer severe deficiency due to pregnancy and lactation, a longitudinal study shows that despite increased urinary calcium losses; increased maternal intestinal calcium absorption appeared to provide the calcium required for fetal bone mineralization, without necessitating a substantial net loss in maternal bone mineral.^11,13 In fact, animal studies in mice show that the bone mineral content increases by 5–10% during pregnancy.^14,15 This increase in bone mineral content probably protects the maternal skeleton from excessive demineralization and fragility during lactation. However, such detailed and comparative studies are not available in humans due to fear of radiation. Several studies are there but they lack comparative baseline values. Some data is available for women who terminated their pregnancy in the first trimester which indicates increased bone resorption, but there are no values taken for full-term mothers.^16,17 Despite these limitations, one may cautiously conclude that bone turnover begins to increase as early as 10 weeks gestation¹² and is mainly increased towards the end of gestation to prepare for transfer of calcium during the third trimester.

A systematic review concluded that despite the transfer of calcium from the maternal skeleton to the fetus, the eventual return of maternal bone mineral density (BMD) to pre-pregnancy values suggests that maternal bone loss may not be permanent.¹⁸ Between 3–7% of maternal bone density is temporarily lost during lactation, but it is recovered after weaning (depending on factors like lactation duration and postpartum amenorrhea) and differ by skeletal site.¹⁹ Many studies show that there is a loss of BMD during pregnancy and there is still a loss of BMD nine months postpartum for mothers that are still breastfeeding. BMD returns to pre-pregnancy values for all sites at 19 months postpartum independent of breastfeeding duration/status.^20,21 Even with frequent pregnancies, bone recovers completely for most women. Supplementary maternal calcium intake does not avert bone loss during lactation or boost skeletal recovery after weaning.¹⁹ Pregnancy and lactation are not related to an increased risk of osteoporotic fractures,^19,22 but BMD increases after both pregnancy and lactation, and may have a protective effect because of the structural rebuilding that occurs after weaning.^23-25 During early pregnancy, there is a considerable increase in calcium absorption. Gradually throughout pregnancy, the part of protein bound in serum declines while the concentrations of free ions seem to remain constant. Vitamin D, calcitonin, and PTH interact to steadily maintain the homeostatic ionic calcium control during pregnancy and lactation as shown in Figure 1.

During early lactation, breast milk calcium was obtained from increased renal calcium conservation and increased bone calcium mobilization. After the resumption of menses, renal calcium conservation appeared to continue and spinal bone mineral was recovered.¹¹

Calcium transfer from mother to fetus

The full-term neonate has about 30 g of calcium which is drawn during pregnancy from the maternal calcium stores to meet its needs for fetal skeletal mineralization and to maintain normal physiological processes across gestation.^26,27 This active transport increases from only several milligrams per day in the first trimester to > 250 mg/d during the last trimester^13,27,28 putting the condition of the mother’s bones and teeth at risk. Markedly high level of total calcium concentration in cord blood compared to maternal serum¹⁷ showed that 80% of the calcium found in the fetal skeleton at birth crossed the placenta during the third trimester and is mostly derived from dietary absorption of calcium during pregnancy.

The suckling neonate requires more calcium in breast milk during six months of exclusive lactation than its fetal requirement, and the baby continues to draw calcium from the mother through breast milk for the duration of lactation. Calcium losses through human breast milk denote ~260 mg/L²⁹ during the breastfeeding period.

Prevalence of hypocalcemia in pregnant women

Though hypocalcemia in pregnancy is not often reported in the literature, it occurs in cases of hypoparathyroidism and in mothers with severe dietary inadequacy.^30,31 Low calcium and magnesium levels have been associated with hypertensive pregnancy disorders according to MJ Keirse’s unpublished observations in 2000,⁹ but a causal effect has not been revealed.

A study in India found the prevalence of hypocalcemia in pregnant women was 66.4% (n = 362/545); all being asymptomatic.³² The mean daily dietary calcium intake and corrected serum calcium level for the group were 325±198 mg and 8.1±1.5 mg/dL, respectively. The daily dietary calcium intake being less than the recommended dietary allowances was a most probable cause of the hypocalcemia. The prevalence of hypocalcemia in pregnant women was 70.55% in a study done in Algeria.³³ A recent study in Pakistan found the prevalence of hypocalcemia to be 60% in patients with preeclampsia.³⁴

Calcium measurement

Laboratories report total serum calcium concentrations and the normal range is 8.5–10.5 mg/dL (2.12 to 2.62 mmol/L). A fall in total serum calcium can be due to a decrease in albumin secondary to liver disease, nephrotic syndrome, or malnutrition. Thus, one must check the ionized calcium (Ca) before concluding a ‘true’ case of hypocalcemia.³⁵ The following formula is used to estimate corrected calcium in clinical practice for albumin: corrected Ca (mmol/L) = Ca measured (mmol/L) + 0.020 or 0.025 (40 - albumin (g/L)).³⁶ In clinical situations, one is only concerned in the ionized calcium, this is measured directly or by estimation, but an ionized calcium test is harder to perform than a serum calcium test since it requires special handling of the blood sample, and it is only done in certain cases. The normal range of ionized calcium is 4.65–5.25 mg/dL (1.16–1.31 mmol/L). A decrease in total serum calcium may not be ‘true’ hypocalcemia, which is due to a decrease in ionized calcium.³⁵

For pregnant mothers, changes in the serum chemistries and calciotropic hormones can easily be mistaken as a disorder of calcium.³⁷ During pregnancy, hemodilution causes the serum albumin and hemoglobin to decrease while the albumin remains low until birth. This fall in albumin causes the total serum calcium to fall to levels normally associated with symptomatic hypocalcemia. During pregnancy, serum phosphate and magnesium levels remain normal while the ionized calcium remains constant during gestation and this shows that the fall in total calcium is due to pregnancy and can be ignored. Any doubt as to whether maternal hypocalcemia is present or not is cleared by computing the albumin-corrected total calcium level or measuring the ionized calcium.

Causes of hypocalcemia in pregnancy

The causes of hypocalcemia in pregnancy are summarized in Table 2.

Table 2. Causes of hypocalcemia.^5-7.

Major causes	Sub-causes
Hypoparathyroidism	Acquired Following thyroid gland surgery either parathyroidectomy or total thyroidectomy (where parathyroid gland is damaged) Infiltrative disease (e.g., hemochromatosis, granulomatous disease (sarcoidosis), thalassemia, and amyloidosis) Metastatic or heavy metal (copper, iron) infiltration of parathyroid gland Due to an autoimmune disease (isolated or often as part of polyglandular autoimmune syndromes) Pseudohypoparathyroidism types 1a, 1b, and 2 Genetic cause Absence of parathyroid glands at birth/developmental defects of parathyroid glands (DiGeorge's syndrome - aplasia of third and fourth pharyngeal pouch) Autosomal dominant hypocalcemia (activating mutation of calcium receptor gene)
Pseudohypoparathyroidism	Lack of response to normal level of PTH
Calcium disorders	Calcium-sensing receptor mutations Inadequate calcium in diet/dietary Ca deficiency cow's milk protein intolerance The natural aging process with increasing parity can cause calcium deficiency disease Disorder that decreases calcium absorption or serum calcium concentration by binding of calcium within the vascular space or by its deposition in tissues, as can occur with short gut, hyperphosphatemia, coeliac disease, tufting enteropathy Renal disease making kidneys excrete more calcium in urine Hungry bone syndrome (persistent hypocalcemia and hypophosphatemia post parathyroidectomy) Acid-base disturbances can cause hypocalcemia (in cases of alkalosis, as the blood's pH rises (low hydrogen cations), this results in an ionization of albumin, making in more negative. Thus, calcium binds to albumin with greater affinity, and this reduces the free calcium) Increased potassium can burn up calcium (potassium aids in maintaining the body’s normal blood calcium balance by decreasing the loss of calcium through urine)
Actual vitamin D deficiency and dependency	Dietary deficiency Lack of sunlight Malabsorption, especially pancreatic disease and coeliac disease
Functional vitamin D deficiency and dependency	Renal disease causes kidneys to lower conversion and activation of vitamin D (lack of 1- α hydroxylation) Liver disease (lack of 25-hydroxylation)
Medication effects	Corticosteroids alter vitamin D Infusion of phosphate or citrated blood transfusion May occasionally develop in the course of treatment with commonly used drugs like antiepileptics and proton pump inhibitors. Such incidents of hypocalcemia can be easily missed due to the coexistence of multiple causative factors
Severe hypomagnesemia inhibits PTH response to hypocalcemia	Renal loss Diuretics, especially loop diuretics Immunosuppressants Miscellaneous drugs, e.g., proton pump inhibitors Gastrointestinal Severe diarrhea Malnutrition Alcoholism
Other causes	Sclerotic metastases Acute pancreatitis (when lipolytic products released from the inflamed pancreas chelate calcium) Fanconi syndrome Septic shock (due to suppression of parathyroid hormone release and decreased vitamin D conversion) Severe hypermagnesemia Surgery Post bariatric surgery Hyperphosphatemia (causes hypocalcemia by poorly understood mechanisms) Renal failure Rhabdomyolysis Tumor lysis Phosphate administration Hypoalbuminemia (most common cause of hypocalcemia) Cirrhosis, nephrosis, malnutrition, burns, chronic illness, and sepsis Widespread osteoblastic metastases Breast cancer

Symptoms/signs of hypocalcemia

The signs and symptoms of hypocalcemia are dependent on the severity, rapidity of development, the rate of decline of serum calcium, and duration of the hypocalcemia varying from an asymptomatic biochemical abnormality to a life-threatening disorder. Mild hypocalcemia is not uncommon, and most patients will have no symptoms while many have vague muscular aches and pains. Many do not realize they are deficient until noticeable problems occur. The symptoms and signs of hypocalcemia are summarized in Table 3.

Table 3. Signs and symptoms of hypocalcemia.

Onset of hypocalcemia	Affected organ	Symptoms/signs
Acute	Neuromuscular	Neuromuscular irritability if the degree of hypocalcemia worsens Acroparesthesias (perioral, fingers, and toes) Tetany, latent (elicited by Trousseau's and Chvostek's signs) Tetany, spontaneous (carpopedal, laryngeal spasm death may occur from asphyxiation if tetany involves the laryngeal muscle) Confusion Seizures Muscle stiffness, myalgias
	Cardiac	QT interval prolongation (death may occur from cardiac arrhythmias) congestive heart failure Hypotension Arrhythmias
	Autonomic symptoms	Biliary colic Bronchospasm Diaphoresis Steatorrhea Gastric achlorhydria
Chronic	Eye	Papilledema Cataracts
	Skin	Dermatitis, dry coarse skin, hyperpigmentation, and eczema
	Brain	Basal ganglia calcification, mental retardation (children), dementia (adults), emotional problems (anxiety, depression), and extrapyramidal symptoms (parkinsonism is most common)

Trousseau’s sign is positively noted by inflating a blood pressure cuff above systolic pressure for up to three minutes and looking for a carpopedal spasm.³⁸

Chvostek’s sign is prompted by tapping the facial nerve below the zygoma (about 1–2 inches anterior to the ear). Ipsilateral contractions of the facial muscle (i.e., twitching first at the angle of the mouth) is a positive sign. Chvostek’s sign can be elicited in up to 25% of individuals with normal levels of serum calcium, thus it is a sensitive but not specific sign of hypocalcemia.³⁸

Complications of hypocalcemia

Links between hypocalcemia and high blood pressure have been reported in recent studies.^39-43 A study done on sheep showed that maternal hypocalcemia caused by maternal fasting in late gestation elevated blood pressure and exhibited reduced uterine blood flow in the sheep.⁴⁴ An inverse correlation between dietary calcium intake and the incidence of pregnancy-induced hypertension⁴⁵ are reported. Low calcium intake during pregnancy may stimulate PTH secretion, increasing intracellular calcium and smooth uterine muscle contractibility which is consistent with induction of preterm labor,⁴⁶ or abortion,⁴⁷ and/or renin release from the kidney, leading to vasoconstriction and retention of sodium and fluid.⁴⁸ These physiological changes can lead to the development of pregnancy-induced hypertension and preeclampsia. Study results have indicated low levels of serum calcium in women presenting with preeclampsia,³⁴ and concluded that calcium supplementation seems to reduce the risk of preeclampsia and the rare incidence of maternal mortality or morbidity.⁴⁹

A study found that pregnant women with the lowest levels of calcium (among those on normal diet and calcium supplements) also had the highest levels of lead in the blood. During pregnancy, hypocalcemia speeds up the production of new bone to replace old, dying bone. Because nearly all the body’s lead is stored away in bone, the lead ‘leaks’ into the bloodstream during bone turnover and can drive up levels of lead in the blood, which could be harmful to a developing baby.⁵⁰

Studies have suggested that very low maternal calcium intake may be a risk for low bone mass in neonates.²⁸ Another study states that maternal calcium metabolic stress, rather than low calcium intake or insufficient vitamin D, has an adverse influence on fetal growth.⁵¹ A systematic review published in the Cochrane Library of calcium supplementation for the prevention of hypertensive disorders reported birth weights were higher in the intervention group compared to the control group in six out of nine studies, and in two of these trials, the difference was statistically significant.⁵² Another meta-analysis of 10 trials (2234 women) found that supplementation with low doses of calcium markedly reduced the risk of preeclampsia 
(RR = 0.38; 95% CI: 0.28–0.52; I² = 0%). This meta-analysis evaluated low-dose supplementation with only calcium (four trials) or in association with vitamin D (three trials), linoleic acid (two trails), or antioxidants (one trial). There was also a reduction in hypertension, low birthweight, and neonatal intensive care unit admission.⁵³

A positive correlation between serum maternal ionized calcium levels and the crown-heel length of the newborn implies maternal vitamin D deficiency could interfere with fetal growth through an effect on maternal calcium homeostasis. Neonatal hyperparathyroidism may develop secondary to maternal hypocalcemia,⁵⁴ causing fetal bone demineralization and growth restriction. Although temporary, skeletal fractures can cause death.⁵⁴

Mean length at birth, birth weight, and one-minute Apgar score were higher in newborns whose mothers had adequate calcium and vitamin D intake than newborns whose mothers had inadequate intake.⁵⁵ A meta-analysis suggests that maternal vitamin D deficiency is associated with an increased risk of small for gestational age infants.⁵⁶

Management

Patients with acute symptomatic hypocalcemia with preeclampsia, cardiac arrhythmias or tetany (calcium level < 1.9 mmol/L (7.0 mg/dL)), or ionized calcium level lower than 0.8 mmol/L should be treated promptly with intravenous calcium replacement with careful electrocardiography monitoring. If magnesium deficiency or alkalosis is present, it should be corrected first.⁵⁷ Most patients can be treated as outpatients with the recommended dose of oral elemental calcium (1–3 g/day) in pregnancy and lactation. Maintaining serum calcium in the low-normal range 8.0 mg/dL (2.00–2.12 mmol/L), maintaining serum phosphorus within a normal range, and maintaining a calcium-phosphate product below 4.4 mmol²/L² (55 mg²/dL²) without developing hypercalciuria, which leads to nephrocalcinosis or nephrolithiasis, and renal impairment.^4,6,7

Complications of low/ high maternal serum calcium in women with hypoparathyroidism

Treatment of pregnant or nursing women with hypoparathyroidism is a challenge due to complications arising from both under- or overtreatment. Maternal hypocalcemia due to hypoparathyroidism has been linked with intrauterine fetal hyperparathyroidism and fetal death while overtreatment leads to maternal hypercalcemia, which can cause complications such as abortion, stillbirth, perinatal death, neonatal tetany, and suppression of the fetal and neonatal parathyroid glands.

Side effects associated with high doses of vitamin D

Supplementation doses of vitamin D should be titrated and gradually increased according to the results of the maternal serum calcium level, which should be frequently tested. Vitamin D dose may need to be tripled from pre-pregnancy needs. However, increasing maternal vitamin D dose increases the fetal calcium concentration and can lead to defects similar to those of idiopathic hypercalcemia of infancy⁵⁸ with features like elfin facies, strabismus, inguinal hernia, mental and growth retardation, craniosynostosis, enamel defects, supravalvular aortic and pulmonary stenosis, early development of secondary sexual characteristics in females, and cryptorchidism in males.⁵⁹ In experimental animals, high doses of vitamin D have been shown to be teratogenic, causing craniofacial abnormalities and supravalvular aortic stenosis syndrome.⁵⁸

Complications related due to under-replacement with vitamin D

In contrast, insufficient maternal vitamin D supplementation predisposes to natal reactive hyperparathyroidism,⁶⁰ which may lead to intracranial bleeding⁶¹ and neonatal rickets with intrauterine fractures.⁶²

Dose adjustment of medications

After delivery, if there is no plan to nurse, the dose could be decreased to the pre-pregnancy level. For a nursing mother, the calcitriol dose should be decreased (to half of the pre-pregnancy dose) since endogenous calcitriol production is stimulated by prolactin and increased production of PTH-related peptide.⁶³

In the patients with hypoparathyroidism, 1,25-dihydroxy ((OH)2) vitamin D replacement should be used only when clearly needed. These are available as vitamin D analogues (e.g., calcitriol, calcifediol, doxercalciferol, and paricalcitol) and come under pregnancy drug category C. Calcitriol and 1α-calcidiol are recommended due to their shorter half-lives, lower risk of toxicity, and clinical experience.³⁷

Although clinical experience with the use of calcitriol during pregnancy is limited, case reports show that management of maternal hypoparathyroidism with calcitriol and calcium during pregnancy is feasible, if serum calcium levels are kept in the lower normal range and calcitriol concentrations are adapted to the physiological needs during pregnancy. Side effects of premature closure of the frontal fontanelle, and stillbirth in 20th week due to complex fetal malformation are reported in two retrospective studies, but in both cases, the causative role of calcitriol administration remains highly questionable. However, to date no serious adverse events were noted in prospective studies.⁶³

The recommended daily calcitriol dose is up to 3 μg/day and up to 9 g/day for daily doses of calcium during pregnancy in patients with hypoparathyroidism.^64,65

Also in lactation, these drugs are excreted through breast milk, hence these are used with caution and frequent monitoring to avoid complications.⁶⁶

Recombinant PTH (teriparatide) is contraindicated in pregnant and lactating women with hypoparathyroidism due to risks of mild growth retardation and reduced motor activity in offspring at higher doses.

One case report illustrates the feasibility of treating hypoparathyroidism during pregnancy with a continuous subcutaneous infusion of recombinant PTH (1–34).⁶⁷ There are no adequate and well-controlled studies in pregnant women. Therefore, PTH (1–34) should not be given as a routine treatment before adequate and well-controlled data proving its safety have become available.

Recombinant PTH is contraindicated in breastfeeding and is classed as a pregnancy category C drug. It is unknown whether it is excreted into human milk, but animal studies have shown that this drug has the potential for tumorigenicity.⁶⁸

Frequent monitoring of calcium levels every 3–4 weeks throughout pregnancy as well as within one week postpartum is important to ensure normal calcium levels in both mother and fetus. Furthermore, monitoring should continue during lactation every 4–6 weeks, as well as during the weaning period to ensure the stability of maternal calcium levels.

Conclusion

Women are at risk when they already have hypocalcemia and must undergo a strain on their bodies to meet the normal needs with the additional needs of calcium during pregnancy and lactation. Many studies show that there is loss of BMD during pregnancy and there is still loss of BMD at nine months postpartum for breastfeeding mothers, which returns to pre-pregnancy values for all sites at 19 months postpartum independent of the breastfeeding duration. Though the mother adapts to this additional requirement, this need could be met by increased dietary calcium intake and calcium supplementation to ensure optimal bone and extra-skeletal health in a woman throughout her life, especially during pregnancy and lactation. Special consideration is necessary for the treatment of women with hypoparathyroidism during pregnancy and nursing. In patients with hypoparathyroidism, 1,25-(OH)2 vitamin D replacement should be used only when needed. A multidisciplinary team including endocrinologists and obstetricians is warranted to ensure appropriate treatment and optimal outcomes.